SCHEMBL492204

SCHEMBL492204

CNC1CC[N]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL667583 1.00
SCHEMBL668058 1.00
SCHEMBL482779 0.84
SCHEMBL294554 0.82
SCHEMBL1855227 0.76
SCHEMBL1579432 0.72 CARM1 (0.31)
SCHEMBL689663 0.72
SCHEMBL9838432 0.72
SCHEMBL666686 0.72
SCHEMBL666631 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112010844-B Preparation method and application of N- (pyrimidine-2-yl) coumarin-7-amine derivative as protein kinase inhibitor 中国药科大学 2023-07-25 CN claimed
US-20230219973-A1 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF MOLECURE S.A. (PL) 2023-07-13 US claimed
CN-113801108-A Protein kinase inhibitor and derivative thereof, preparation method, pharmaceutical composition and application 中国药科大学 2021-12-17 CN claimed
CN-113549018-A Protein kinase inhibitor and derivative thereof, preparation method, pharmaceutical composition and application 中国药科大学 2021-10-26 CN claimed
CN-112010844-A Preparation method and application of N- (pyrimidine-2-yl) coumarin-7-amine derivative as protein kinase inhibitor 中国药科大学 2020-12-01 CN claimed
US-20190119272-A1 TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS INCYTE CORPORATION 2019-04-25 US claimed
US-10125133-B2 Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors INCYTE CORPORATION (US) 2018-11-13 US claimed
US-20170369488-A1 TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS INCYTE CORPORATION 2017-12-28 US claimed
US-9695167-B2 Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors INCYTE CORPORATION (US) 2017-07-04 US claimed
WO-2016007722-A1 TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS INCYTE CORPORATION (US) 2016-01-14 WO claimed
WO-2004083207-A1 NAPHTHYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS ABBOTT LABORATORIES (US) 2004-09-30 WO claimed
US-20030232818-A1 Antibacterial compounds ABBVIE INC. 2003-12-18 US claimed
EP-0614664-B2 Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-01-08 EP claimed
EP-0614664-B1 Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-09-16 EP claimed
EP-0160284-B1 QUINO-BENOXAZINE ANTIBACTERIAL COMPOUNDS ABBOTT LABORATORIES (US) 1990-10-24 EP claimed
EP-0162333-B1 QUINO-BENZOTHIAZINE ANTIBACTERIAL COMPOUNDS ABBOTT LABORATORIES (US) 1990-06-27 EP claimed
US-4607032-A Quino-benoxazine antibacterial compounds ABBOTT LABORATORIES (US) 1986-08-19 US claimed
EP-0162333-A1 Quino-benzothiazine antibacterial compounds ABBOTT LABORATORIES (US) 1985-11-27 EP claimed
EP-0160284-A1 Quino-benoxazine antibacterial compounds ABBOTT LABORATORIES (US) 1985-11-06 EP claimed
US-4533663-A Quino-benzothiazine antibacterial compounds ABBOTT LABORATORIES (US) 1985-08-06 US claimed